Growing incidence of chronic diseases such as lymphedema is one the factors majorly responsible for the growth of lymphedema diagnostics market. Various technological advancements are being incorporated to enhance the usage of lymphedema diagnostics, so that earlier detection can be followed by treatment without losing any downtime.
The companies operating in the lymphedema diagnostics market are working toward adopting computer-aided diagnosis in order to screen lower extremity lymphedema in the pelvic computed tomography images using deep learning.
They are also exploring development of the predictive models for this ailment by using therapy data and the data obtained from blood tests.
Lymphedema is referred to as a medical condition caused due to damage of the lymphatic system, congenital defects, or trauma. The tissues of the affected area get swollen when lymphatic fluid crosses the lymphatic transportation capacity in the form of an unusual quantity of protein-rich food.
There are two types of lymphedema, namely primary and secondary. The former one may occur at birth (congenital) or at the start of puberty (praecox) or in adulthood (tarda).
Secondary lymphedema may be an outcome of surgery or radiation therapy and is amongst the common outcomes of cancer treatments that do away with or harm lymph nodes/vessels.
However, higher prices of diagnostic imaging tools apart from restricted supply of helium and shorter life-span of radiopharmaceuticals is likely of downsizing the lymphedema diagnostics market during the forecast period.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Lymphedema is one of the long-lasting conditions in which additional fluid gets collected in tissues of the body, thereby resulting in swelling. Genetic mutations are one of the primary reasons behind development of lymphatic system. Moreover, inflammatory conditions, radiation therapy may lead to lymphedema.
Lymphedema is also called lymphatic obstruction, which basically affects legs and arms. Certain patients are likely of witnessing swelling in genitals, chest, and head as well. As of now, the foundation of majority of risk models comprises risk to cancer and its treatment.
Technological advancements have improved the diagnostic solutions. For instance, bioimpedance spectroscopy (BIS) is simple to integrate into the existing workflows and scalable. These properties help in tracking and addressing future pertaining to lymphedema.
BIS helps in the detection of lymphedema at the earliest stage in order to facilitate avoidance of cancer-related lymphedema for those at a higher risk. Massive investments by government and non-government agencies are expected to add to the growth of lymphedema diagnostics market during the forecast period.
The key participants are increasingly investing in new diagnostics modalities in order to increase their market share. ImpediMed is one of the medical technology companies based in Australia with operations in Europe and the U.S.
It uses bio-impedance spectroscopy (BIS) technology for generating powerful data in order to improve patient health. In other words, it uses bioimpedance in the non-invasive clinical assessment as well as monitoring of status of fluids.
The modern-day product portfolio of lymphedema diagnostics includes medical devices to help surgeons, oncologists, radiation oncologists, and therapists in clinical assessment of patient to determine the potential onset of secondary lymphedema.
In June 2020, ImpediMed inked an agreement with the U.S. Oncology Network. In order to facilitate diagnosis of lymphedema at an earlier stage with bioimpedance spectroscopy instrument and analyzing the tissue composition and status of extracellular fluid.
Continual investment in new-fangled diagnostic modalities is thus expanding the lymphedema diagnostics market size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest lymphedema diagnostics market analysis, North America held the largest share of lymphedema diagnostic imaging landscape in 2023 and the dominance is expected to continue during the forecast period. This is attributed to growing incidence of chronic diseases and rise in awareness regarding the advantages offered by early diagnosis of lymphedema.
Asia Pacific’s noticeable lymphedema diagnostic market growth is ascribed to raised consciousness quotient regarding real-time lymphedema diagnosis amongst the populace. Additionally, there is an increase in several R&D activities related to development of lymphedema diagnostic procedures in countries such as India and China.
The key participants in the lymphedema diagnostics market are devising new products to strengthen their position.
GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, Canon Inc., Shimadzu Corporation, Stryker Corporation, Fluoptics, United Imaging Healthcare, Hitachi, Ltd., and Esaote SpA are some of the key players covered in the lymphedema diagnostics market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 41.9 Mn |
| Market Forecast (Value) in 2034 | US$ 70.7 Mn |
| Growth Rate (CAGR) | 4.8% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 41.8 Bn in 2023
It is projected to grow at a CAGR of 4.8% from 2024 to 2034
Growing prevalence of chronic diseases such as lymphedema and rise in investment in new diagnostics modalities
Diagnostic centers segment accounted for the largest share in 2023
North America was the dominant region in 2023
GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, Canon Inc., Shimadzu Corporation, Stryker Corporation, Fluoptics, United Imaging Healthcare, Hitachi, Ltd., and Esaote SpA
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Lymphedema Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Lymphedema Diagnostics Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Lymphedema Diagnostics Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technology, 2020-2034
6.3.1. Lymphoscintigraphy
6.3.2. Near-Infrared Fluorescence Imaging
6.3.3. Magnetic Resonance Imaging (MRI)
6.3.4. Ultrasound Imaging
6.3.5. Computed Tomography (CT)
6.3.6. Others
6.4. Market Attractiveness Analysis, by Technology
7. Global Lymphedema Diagnostics Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2020-2034
7.3.1. Hospitals
7.3.2. Diagnostic Centers
7.3.3. Research & Academic Institutes
7.4. Market Attractiveness Analysis, by End-user
8. Global Lymphedema Diagnostics Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2020-2034
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Lymphedema Diagnostics Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Technology, 2020-2034
9.3.1. Lymphoscintigraphy
9.3.2. Near-Infrared Fluorescence Imaging
9.3.3. Magnetic Resonance Imaging (MRI)
9.3.4. Ultrasound Imaging
9.3.5. Computed Tomography (CT)
9.3.6. Others
9.4. Market Value Forecast, by End-user, 2020-2034
9.4.1. Hospitals
9.4.2. Diagnostic Centers
9.4.3. Research & Academic Institutes
9.5. Market Value Forecast, by Country, 2020-2034
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Technology
9.6.2. By End-user
9.6.3. By Country
10. Europe Lymphedema Diagnostics Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Technology, 2020-2034
10.3.1. Lymphoscintigraphy
10.3.2. Near-Infrared Fluorescence Imaging
10.3.3. Magnetic Resonance Imaging (MRI)
10.3.4. Ultrasound Imaging
10.3.5. Computed Tomography (CT)
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Diagnostic Centers
10.4.3. Research & Academic Institutes
10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Technology
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Lymphedema Diagnostics Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Technology, 2020-2034
11.3.1. Lymphoscintigraphy
11.3.2. Near-Infrared Fluorescence Imaging
11.3.3. Magnetic Resonance Imaging (MRI)
11.3.4. Ultrasound Imaging
11.3.5. Computed Tomography (CT)
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Diagnostic Centers
11.4.3. Research & Academic Institutes
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Technology
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Lymphedema Diagnostics Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Technology, 2020-2034
12.3.1. Lymphoscintigraphy
12.3.2. Near-Infrared Fluorescence Imaging
12.3.3. Magnetic Resonance Imaging (MRI)
12.3.4. Ultrasound Imaging
12.3.5. Computed Tomography (CT)
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Diagnostic Centers
12.4.3. Research & Academic Institutes
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Technology
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Lymphedema Diagnostics Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Technology, 2020-2034
13.3.1. Lymphoscintigraphy
13.3.2. Near-Infrared Fluorescence Imaging
13.3.3. Magnetic Resonance Imaging (MRI)
13.3.4. Ultrasound Imaging
13.3.5. Computed Tomography (CT)
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Diagnostic Centers
13.4.3. Research & Academic Institutes
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Technology
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2023)
14.3. Company Profiles
14.3.1. GE HealthCare
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Koninklijke Philips N.V.
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Siemens Healthineers
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Canon Inc.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Shimadzu Corporation
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Stryker Corporation
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Fluoptics
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. United Imaging Healthcare
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. Hitachi, Ltd.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
14.3.10. Esaote SpA
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview
List of Tables
Table 01: Global Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 02: Global Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 03: Global Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 04: North America Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 05: North America Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 06: North America Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 07: Europe Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 08: Europe Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 09: Europe Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 10: Asia Pacific Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 11: Asia Pacific Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 12: Asia Pacific Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Latin America Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Latin America Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 15: Latin America Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 16: Middle East & Africa Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Middle East & Africa Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 18: Middle East & Africa Lymphedema Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Lymphedema Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Lymphedema Diagnostics Market Revenue (US$ Mn), by Technology, 2023
Figure 03: Global Lymphedema Diagnostics Market Value Share, by Technology, 2023
Figure 04: Global Lymphedema Diagnostics Market Revenue (US$ Mn), by End-user, 2023
Figure 05: Global Lymphedema Diagnostics Market Value Share, by End-user, 2023
Figure 06: Global Lymphedema Diagnostics Market Value Share, by Region, 2023
Figure 07: Global Lymphedema Diagnostics Market Value (US$ Mn) Forecast, 2020-2034
Figure 08: Global Lymphedema Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 09: Global Lymphedema Diagnostics Market Attractiveness Analysis, by Technology, 2020-2034
Figure 10: Global Lymphedema Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 11: Global Lymphedema Diagnostics Market Attractiveness Analysis, by End-user, 2020-2034
Figure 12: Global Lymphedema Diagnostics Market Value Share Analysis, by Region, 2023 and 2034
Figure 13: Global Lymphedema Diagnostics Market Attractiveness Analysis, by Region, 2020-2034
Figure 14: North America Lymphedema Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 15: North America Lymphedema Diagnostics Market Attractiveness Analysis, by Country, 2020-2034
Figure 16: North America Lymphedema Diagnostics Market Value Share Analysis, by Country, 2023 and 2034
Figure 17: North America Lymphedema Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 18: North America Lymphedema Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 19: North America Lymphedema Diagnostics Market Attractiveness Analysis, by Technology, 2020-2034
Figure 20: North America Lymphedema Diagnostics Market Attractiveness Analysis, by End-user, 2020-2034
Figure 21: Europe Lymphedema Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 22: Europe Lymphedema Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 23: Europe Lymphedema Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 24: Europe Lymphedema Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 25: Europe Lymphedema Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 26: Europe Lymphedema Diagnostics Market Attractiveness Analysis, by Technology, 2020-2034
Figure 27: Europe Lymphedema Diagnostics Market Attractiveness Analysis, by End-user, 2020-2034
Figure 28: Asia Pacific Lymphedema Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 29: Asia Pacific Lymphedema Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 30: Asia Pacific Lymphedema Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 31: Asia Pacific Lymphedema Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 32: Asia Pacific Lymphedema Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Asia Pacific Lymphedema Diagnostics Market Attractiveness Analysis, by Technology, 2020-2034
Figure 34: Asia Pacific Lymphedema Diagnostics Market Attractiveness Analysis, by End-user, 2020-2034
Figure 35: Latin America Lymphedema Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 36: Latin America Lymphedema Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 37: Latin America Lymphedema Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 38: Latin America Lymphedema Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 39: Latin America Lymphedema Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 40: Latin America Lymphedema Diagnostics Market Attractiveness Analysis, by Technology, 2020-2034
Figure 41: Latin America Lymphedema Diagnostics Market Attractiveness Analysis, by End-user, 2020-2034
Figure 42: Middle East & Africa Lymphedema Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 43: Middle East & Africa Lymphedema Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 44: Middle East & Africa Lymphedema Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 45: Middle East & Africa Lymphedema Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 46: Middle East & Africa Lymphedema Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 47: Middle East & Africa Lymphedema Diagnostics Market Attractiveness Analysis, by Technology, 2020-2034
Figure 48: Middle East & Africa Lymphedema Diagnostics Market Attractiveness Analysis, by End-user, 2020-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Lymphedema Diagnostics Market
